Supplementary Figure 3 from A Recombinant Immunotoxin against the Tumor-Associated Antigen Mesothelin Reengineered for High Activity, Low Off-Target Toxicity, and Reduced Antigenicity
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 204K, Pharmacokinetics of SS1-LR/GGS/8M in mice
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362533998
